Mark Dearman is a partner in Robbins Geller Rudman & Dowd LLP’s Boca Raton office, where his practice focuses on consumer fraud, securities fraud, mass torts, antitrust, and whistleblower litigation.
Lawdragon Honors
Dearman, along with other Robbins Geller attorneys, is currently leading the effort on behalf of cities and counties around the country in In re National Prescription Opiate Litigation, No. 1:17-md-02804-DAP (N.D. Ohio). He was appointed to the Plaintiffs’ Steering Committee in In re Zantac (Ranitidine) Products Liability Litigation, No. 9:20-md-02924-RLR (S.D. Fla.), and as Chair of the Plaintiffs’ Executive Committee in In re Apple Inc. Device Performance Litigation, No. 5:18-md-02827-EJD (N.D. Cal.), Dearman, along with co-counsel, obtained a $310 million settlement. His other recent representative cases include serving as class counsel in In re Juul Labs, Inc., Marketing, Sales Practices, and Products Liability Litigation, No. 3:19-md-02913-WHO (N.D. Cal.); In re McKinsey & Co., Inc. National Prescription Opiate Consultant Litigation, No. 3:21-md-02996-CRB (N.D. Cal.); In re Facebook Biometric Information Privacy Litigation, No. 3:15-cv-03747-JD (N.D. Cal.) ($650 million recovery in a class action concerning Facebook’s alleged privacy violations through its collection of user’s biometric identifiers without informed consent); In re EpiPen (Epinephrine Injection, USP) Marketing, Sales Practices & Antitrust Litigation, No. 2:17-md-02785-DDC-TJJ (D. Kan.) ($609 million total recovery achieved weeks prior to trial in certified class action alleging antitrust claims involving the illegal reverse payment settlement to delay the generic EpiPen); In re FieldTurf Artificial Turf Sales & Marketing Practices Litigation, No. 3:17-md-02779-MAS-TJB (D.N.J.); In re Sony Gaming Networks & Customer Data Security Breach Litigation, 903 F. Supp. 2d 942 (S.D. Cal. 2012); In re Volkswagen “Clean Diesel” Marketing, Sales Practices, & Products Liability Litigation, 2016 U.S. Dist. LEXIS 1357 (N.D. Cal. Jan. 5, 2016); In re Aluminum Warehousing Antitrust Litigation, 95 F. Supp. 3d 419 (S.D.N.Y. 2015); In re Liquid Aluminum Sulfate Antitrust Litigation, No. 2:16-md-2687-MCA-MAH (D.N.J.); In re Winn-Dixie Stores, Inc. Shareholder Litigation, No. 16-2011-CA-010616 (Fla. 4th Jud. Cir. Ct., Duval Cnty.); Gemelas v. Dannon Co. Inc., No. 1:08-cv-00236-DAP (N.D. Ohio); and In re AuthenTec, Inc. Shareholder Litigation, No. 05-2012-CA-57589 (Fla. 18th Jud. Cir. Ct., Brevard Cnty.).
Dearman was a member of the faculty of the inaugural Mass Tort MDL Certificate Program at the Bolch Judicial Institute of Duke Law School in March 2019 and was also a member of the faculty of the Program in 2020. He also served as a faculty member of the Advanced Mass Tort MDL Certificate Program at the Bolch Judicial Institute of Duke Law School in May 2023. Before joining Robbins Geller, Dearman spent several years defending Fortune 500 companies in all aspects of litigation, with an emphasis in complex commercial litigation, consumer claims, and mass torts (products liability and personal injury). He went on to found the firm of Dearman & Gerson, where he continued to defend many publicly traded corporations for over 12 years. Over the last 30 years of practice, Dearman has obtained extensive jury trial experience on the plaintiffs’ side, protecting the rights of consumers throughout the United States.
